Identification and Development of Therapeutics for COVID-19

Mostrar otras versiones (1)

After emerging in China in late 2019, the novel coronavirus SARS-CoV-2 spread worldwide and as of mid-2021 remains a significant threat globally. Only a few coronaviruses are known to infect humans, and only two cause infections similar in severity to SARS-CoV-2: Severe acute respiratory syndrome-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Rando, Halie M., Wellhausen, Nils, Ghosh, Soumita, Lee, Alexandra J., Dattoli, Anna Ada, Hu, Fengling, Byrd, James Brian, Rafizadeh, Diane N., Lordan, Ronan, Qi, Yanjun, Sun, Yuchen, Brueffer, Christian, Field, Jeffrey M., Guebila, Marouen Ben, Jadavji, Nafisa M., Skelly, Ashwin N., Ramsundar, Bharath, Wang, Jinhui, Goel, Rishi Raj, Park, YoSon, Boca, Simina M., Gitter, Anthony, Greene, Casey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cornell University 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941644/
https://www.ncbi.nlm.nih.gov/pubmed/33688554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941644/
https://www.ncbi.nlm.nih.gov/pubmed/33688554

Ejemplares similares